Skip to main content
Erschienen in: European Journal of Pediatrics 6/2016

27.11.2015 | Case Report

Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion

verfasst von: Alkim Oden Akman, Ozge Basaran, Derya Ozyoruk, Unsal Han, Tulin Sayli, Nilgun Cakar

Erschienen in: European Journal of Pediatrics | Ausgabe 6/2016

Einloggen, um Zugang zu erhalten

Abstract

Castleman disease (CD) is a rare poorly understood lymphoproliferative disorder. Pediatric onset CD has been reported before. However, most of them have benign unicentric pattern. Multicentric CD (MCD) is quite rare in children. Herein, we report a 13-year-old adolescent boy with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation.
Conclusion: MCD should be considered in the differential diagnosis of pleural and/or pericardial effusion with unexplained lymph nodes in children.
What is Known
Pediatric Castleman disease (CD) most commonly occurs in the unicentric form, which typically is asymptomatic and cured by lymph node excision.
The diagnosis of MCD can be difficult owing to the heterogeneity of presentation and potential for nonspecific multisystem involvement.
What is New
A 13-year-old adolescent boy was diagnosed with MCD of the hyaline vascular variant presenting with pleural and pericardial effusion, which is an uncommon presentation.
In a pediatric patient with fever, pleural-pericardial effusion and multiple lymph nodes, MCD should be considered in differantial diagnosis.
Literatur
1.
Zurück zum Zitat Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot N Engl J Med 251(10):396–400CrossRefPubMed Castleman B, Towne VW (1954) Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot N Engl J Med 251(10):396–400CrossRefPubMed
2.
Zurück zum Zitat Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of Castleman’s disease. Am J Hematol 87(11):997–1002CrossRefPubMedPubMedCentral Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, Menke DM, Weisenburger DD, Ristow K, Dogan A, Habermann TM (2012) The clinical spectrum of Castleman’s disease. Am J Hematol 87(11):997–1002CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D’Amore ES, D’Angelo P (2011) Castleman's disease in childhood: report of three cases and review ofthe literature. Ital J Pediatr. 20;37:50 Farruggia P, Trizzino A, Scibetta N, Cecchetto G, Guerrieri P, D’Amore ES, D’Angelo P (2011) Castleman's disease in childhood: report of three cases and review ofthe literature. Ital J Pediatr. 20;37:50
4.
Zurück zum Zitat Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2012) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, Ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima and Nagoya meetings. J Clin Exp Hematop 53(1):57–61CrossRef Kawabata H, Takai K, Kojima M, Nakamura N, Aoki S, Nakamura S, Kinoshita T, Masaki Y (2012) Castleman-Kojima disease (TAFRO syndrome): a novel systemic inflammatory disease characterized by a constellation of symptoms, namely, thrombocytopenia, Ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly : a status report and summary of Fukushima and Nagoya meetings. J Clin Exp Hematop 53(1):57–61CrossRef
5.
Zurück zum Zitat Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, Kashimura M, Masawa N, Nakamura S (2011) Multicentric Castleman’s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20(1):44–50CrossRefPubMed Kojima M, Nakamura N, Tsukamoto N, Yokohama A, Itoh H, Kobayashi S, Kashimura M, Masawa N, Nakamura S (2011) Multicentric Castleman’s disease representing effusion at initial clinical presentation: clinicopathological study of seven cases. Lupus 20(1):44–50CrossRefPubMed
6.
Zurück zum Zitat Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H (2013) Japanese variant of multicentric castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed Masaki Y, Nakajima A, Iwao H, Kurose N, Sato T, Nakamura T, Miki M, Sakai T, Kawanami T, Sawaki T, Fujita Y, Tanaka M, Fukushima T, Okazaki T, Umehara H (2013) Japanese variant of multicentric castleman’s disease associated with serositis and thrombocytopenia—a report of two cases: is TAFRO syndrome (Castleman-Kojima disease) a distinct clinicopathological entity? J Clin Exp Hematop 53(1):79–85CrossRefPubMed
7.
Zurück zum Zitat Parez N, Bader-Meunier B, Roy CC, Dommergues JP (1999) Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr 158(8):631–7CrossRefPubMed Parez N, Bader-Meunier B, Roy CC, Dommergues JP (1999) Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr 158(8):631–7CrossRefPubMed
8.
Zurück zum Zitat Smith C, Lee-Miller C, Dishop MK, Cost C, Wang M, Asturias EJ (2014) Multicentric Castleman disease presenting with fever. J Pediatr 165(6):1261–5CrossRefPubMed Smith C, Lee-Miller C, Dishop MK, Cost C, Wang M, Asturias EJ (2014) Multicentric Castleman disease presenting with fever. J Pediatr 165(6):1261–5CrossRefPubMed
9.
Zurück zum Zitat Soumerai JD, Sohani AR, Abramson JS (2014) Diagnosis and management of Castleman disease. Cancer Control 21(4):266–78PubMed Soumerai JD, Sohani AR, Abramson JS (2014) Diagnosis and management of Castleman disease. Cancer Control 21(4):266–78PubMed
10.
Zurück zum Zitat Van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R (2010) Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol 28(23):3701–8CrossRefPubMed Van Rhee F, Fayad L, Voorhees P, Furman R, Lonial S, Borghaei H, Sokol L, Crawford J, Cornfeld M, Qi M, Qin X, Herring J, Casper C, Kurzrock R (2010) Siltuximab, a novel anti-interleukin-6 monoclonal antibody, for Castleman’s disease. J Clin Oncol 28(23):3701–8CrossRefPubMed
Metadaten
Titel
Atypical presentation of multicentric Castleman disease in a pediatric patient: pleural and pericardial effusion
verfasst von
Alkim Oden Akman
Ozge Basaran
Derya Ozyoruk
Unsal Han
Tulin Sayli
Nilgun Cakar
Publikationsdatum
27.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Pediatrics / Ausgabe 6/2016
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-015-2674-6

Weitere Artikel der Ausgabe 6/2016

European Journal of Pediatrics 6/2016 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.